A retrospective observational study of rapid titration of venetoclax (VEN) in patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Babalola, Tijesuni
Ayers, Emily C.
Douvas, Michael G.
Foster, Laahn
Densmore, John
Williams, Michael E.
Portell, Craig Anthony
机构：
[1] Univ Virginia Hlth, Charlottesville, VA USA
[2] Univ Virginia, Div Hematol & Oncol, Dept Med, Charlottesville, VA USA
[3] Univ Virginia, Charlottesville, VA USA
[4] Univ Virginia, Sch Med, Charlottesville, VA USA
[5] Univ Virginia, Med Ctr, Charlottesville, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19018
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).
    Lee, Hun Ju
    Choi, Michael Y.
    Siddiqi, Tanya
    Barrientos, Jacqueline Claudia
    Wierda, William G.
    Isufi, Iris
    Tuscano, Joseph M.
    Lamanna, Nicole
    Subbiah, Suki
    Koff, Jean Louise
    Leslie, Lori Ann
    Goldenberg, Alec
    Chung, Gina G.
    Breitmeyer, James Bradley
    Hsu, Frank J.
    Wang, Michael
    Jamieson, Catriona
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Phase 1/2 study of zilovertamab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).
    Lee, Hun Ju
    Choi, Michael Y.
    Siddiqi, Tanya
    Rhodes, Joanna Meehan
    Wierda, William G.
    Isufi, Iris
    Tuscano, Joseph M.
    Lamanna, Nicole
    Subbiah, Suki
    Koff, Jean Louise
    Leslie, Lori Ann
    Goldenberg, Alec
    Chung, Gina G.
    Yazji, Salim
    Wang, Yao
    Breitmeyer, James Bradley
    Wang, Michael
    Jamieson, Catriona
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] BUDGET IMPACT OF PIRTOBRUTINIB FOR PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) OR CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) IN THE UNITED STATES (US)
    Winfree, K. B.
    Zhang, K. H.
    Muehlenbein, C. E.
    Panjic, E. H.
    Ale-Ali, A.
    Graham, C. N.
    VALUE IN HEALTH, 2024, 27 (06) : S143 - S143
  • [4] Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)
    Lee, Hun Ju
    Choi, Michael
    Siddiqi, Tanya
    Barrientos, Jacqueline
    Wierda, William G.
    Isufi, Iris
    Tuscano, Joseph
    Lamanna, Nicole
    Subbiah, Suki
    Koff, Jean L.
    Leslie, Lori A.
    Goldenberg, Alec
    Chung, Gina G.
    Breitmeyer, James B.
    Yazji, Salim
    Wang, Yao
    Wang, Michael
    Jamieson, Catriona
    Kipps, Thomas J.
    BLOOD, 2021, 138
  • [5] Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)
    Lee, Hun Ju
    Choi, Michael Y.
    Siddiqi, Tanya
    Rhodes, Joanna M.
    Wierda, William G.
    Isufi, Iris
    Tuscano, Joseph M.
    Lamanna, Nicole
    Subbiah, Suki
    Koff, Jean L.
    Leslie, Lori
    Goldenberg, Alec
    Chung, Gina G.
    Breitmeyer, James B.
    Yazji, Salim
    Wang, Michael
    Jamieson, Catriona
    Kipps, Thomas J.
    BLOOD, 2022, 140
  • [6] Characteristics of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL) Patients Treated with Acalabrutinib in a Real World Setting in the United States
    Ryan, Kellie
    Burudpakdee, Chakkarin
    Zhao, Xiaohui
    Le, Hannah
    Near, Aimee
    BLOOD, 2019, 134
  • [7] CD5+B-cell Lymphoproliferative Disorders: Beyond Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
    Jevremovic, D.
    Dronca, R. S.
    Morice, W. G.
    Remstein, E. D.
    Kurtin, P. J.
    Zent, C. S.
    Hanson, C. A.
    MODERN PATHOLOGY, 2009, 22 : 269A - 269A
  • [8] CD5+B-cell Lymphoproliferative Disorders: Beyond Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
    Jevremovic, D.
    Dronca, R. S.
    Morice, W. G.
    Remstein, E. D.
    Kurtin, P. J.
    Zent, C. S.
    Hanson, C. A.
    LABORATORY INVESTIGATION, 2009, 89 : 269A - 269A
  • [9] Ibrutinib in Patients (Pts) with Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL) with Relapsed Disease Post Allogeneic Stem Cell Transplantation (alloSCT)
    Khouri, Issa F.
    Jabbour, Elias
    Saliba, Rima M.
    Ledesma, Celina
    Burger, Jan A.
    O'Brien, Susan
    Gulbis, Alison M.
    BLOOD, 2015, 126 (23)
  • [10] PATIENT-REPORTED EXPERIENCES WITH TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL): RESULTS OF A QUANTITATIVE SURVEY
    Schenkel, Brad
    Naim, Ahmad
    Roland, Barbara
    Wyant, Susan
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E164 - E164
12345